PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 ---- NDC 50268-517-15

Reported: March 27, 2019 Initiated: March 5, 2019 #D-1044-2019

Product Description

Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 ---- NDC 50268-517-15

Reason for Recall

CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified

Details

Recalling Firm
AVKARE Inc.
Units Affected
N/A
Distribution
Nationwide.
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
Losartan Potassium Tablets USP 50 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only, Manufactured for: AvKARE Inc. Pulaski, TN 38478 ---- NDC 50268-517-15. Recalled by AVKARE Inc.. Units affected: N/A.
Why was this product recalled?
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified
Which agency issued this recall?
This recall was issued by the FDA Drug on March 27, 2019. Severity: Moderate. Recall number: D-1044-2019.